JP MORGAN/CALL/WALGREENS BOOTS ALLIANCE/26/0.1/19.07.24 Share Price

Warrant

DE000JB8NHV4

Market Closed - Börse Stuttgart 02:44:00 20/06/2024 pm IST
0.002 EUR 0.00% Intraday chart for JP MORGAN/CALL/WALGREENS BOOTS ALLIANCE/26/0.1/19.07.24
Current month-33.33%
1 month-60.00%

Static data

Product typeWarrants
Buy / SellCALL
Underlying WALGREENS BOOTS ALLIANCE, INC.
Issuer J.P. Morgan
WKN JB8NHV
ISINDE000JB8NHV4
Date issued 14/12/2023
Strike 26 $
Maturity 19/07/2024 (19 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.33
Lowest since issue 0.001
Delta0.06x
Omega 9.284
Premium62.02x
Gearing158.05x
Moneyness 0.6196
Difference Strike 13.9 $
Difference Strike %+53.48%
Spread 0.015
Spread %88.24%
Theoretical value 0.009500
Implied Volatility 98.69 %
Total Loss Probability 96.74 %
Intrinsic value 0.000000
Present value 0.009500
Break even 26.10 €
Theta-0.01x
Vega0x
Rho0x

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
12.1 USD
Average target price
17.08 USD
Spread / Average Target
+41.24%
Consensus